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Th1 and Th17 subtype effector CD4þ T cells are thought
to play a critical role in the pathogenesis of human and
experimental crescentic glomerulonephritis. The time course,
mechanism, and functions of Th1 and Th17 cell recruitment,
and their potential interaction in glomerulonephritis,
however, remain to be elucidated. We performed
interventional studies using IL-17- and IFN-c-gene-deficient
mice, as well as neutralizing antibodies that demonstrated
the importance of the Th17-mediated immune response
during the early phase of the disease. At a later stage, we
found that Th1 cells were critical mediators of renal tissue
injury. Early recruitment of IL-17-producing Th17 cells
triggered expression of the chemokine CXCL9 in the kidney
that drove the infiltration of Th1 cells bearing its receptor
CXCR3. At a later stage, Th1 cell–derived IFN-c was found to
inhibit local chemokine CCL20 expression, acting through its
receptor CCR6 on Th17 cells, thereby limiting the renal Th17
immune response. Thus, our findings provide mechanistic
evidence for a cytokine–chemokine-driven feedback loop that
orchestrates the observed differential Th1 and Th17 cell
infiltration into the inflamed kidney. This contributes to the
observed time-dependent function of these two major
pathogenic effector CD4þ T cell subsets in crescentic
glomerulonephritis.
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Four decades ago, the first in vitro evidence suggesting a role
of cell-mediated immune response in human glomerulone-
phritis1 was met with great criticism by leading authorities in
the field.2 Nevertheless, subsequent work in human and experi-
mental glomerulonephritis provided clear evidence that T
cell–mediated immunity can profoundly contribute to renal
tissue injury.3–10 Today, it is generally accepted that, in partic-
ular, CD4þ T helper (Th) cells play a central role in the patho-
genesis of proliferative and crescentic glomerulonephritis.11
On the basis of their cytokine secretion patterns and trans-
cription factor expression, CD4þ T cells can be classified into
four major subsets, namely Th1, Th2, Th17, and regulatory
T cells (Tregs), although further separate CD4þ T cell lineages
such as Th9, Th22, and follicular Th cells might exist.12 In the
past few years, work by the Holdsworth–Tipping–Kitching
group demonstrated the importance of interferon-g (IFN-g)-
producing Th1 cells in renal tissue injury in experimental
models of crescentic glomerulonephritis.13,14 Recently, we
and others identified IL-17-producing Th17 cells in the
inflamed kidney,15,16 and demonstrated the functional role
of the Th17 immune response in glomerulonephritis.16–20
However, the precise time course of the appearance of Th1
and Th17 cells in the kidney, their effector functions, and
their potential interaction in crescentic glomerulonephritis
remain to be elucidated.21,22
The aim of this study was to carry out a detailed analysis
of the time course, function, and potential interaction of
renal and systemic Th1 and Th17 immune responses during
the development of crescentic glomerulonephritis. We there-
fore induced the CD4 T cell–dependent model of nephrotoxic
nephritis23 in mice to address the following specific
questions: (i) What are the time kinetics of renal and
systemic Th1 and Th17 immune responses? (ii) What is their
time-dependent function in the development of immune-
mediated kidney injury? (iii) Is there cross-regulation
between IL-17- and IFN-g-producing T cells in the kidney
during the course of the glomerulonephritis, and, if so, what
are the underlying mechanisms?
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RESULTS
Time course of experimental crescentic glomerulonephritis
In the first step, we characterized the time course of renal
tissue injury and T cell recruitment, as well as the T cell
activation status in a murine model of crescentic glomer-
ulonephritis (Figure 1). To assess renal tissue damage, periodic
acid–Schiff (PAS)-stained kidney sections were evaluated for
the presence of glomerular crescents as described pre-
viously.24 The frequency of glomerular crescents increased
continuously in nephritic mice until day 20 (Figure 1a).
Representative PAS-stained kidney sections of mice with
nephrotoxic nephritis (NTN) on day 5 showed focal glo-
merular and tubular alterations with partial destruction of
regular tissue structures (Figure 1a). Even more pronounced
glomerular hypercellularity and formation of cellular cres-
cents, capillary aneurysms, and intraglomerular deposition of
PAS-positive material was detectable at day 20 (Figure 1a).
To investigate renal T cell infiltration during the stages of
the disease, kidney sections from nephritic mice at indicated
time points were immunohistochemically stained for the pan
T cell marker CD3. Representative staining patterns of
control and nephritic wild-type animals from day 5 to day
20 are shown in Figure 1b. Quantification revealed a con-
tinuous accumulation of renal T cells in the tubulointerstitial
compartment (Figure 1b, upper panel) and to a lesser degree
in the glomerular compartment (Figure 1b, lower panel).
Flow cytometry–based analysis of CD44 and CD62L
expression on CD4þ T cells allows the discrimination
between naı¨ve T cells (CD44low CD62Lþ ), central memory
T cells (CD44high CD62Lþ ), and effector CD4þ T cells
(CD44high CD62L) in the peripheral blood, the spleen, and
the kidney (Figure 1c). Kidneys of control mice already
contained a large fraction of effector CD4þ cells (69%) when
compared with the peripheral blood (8%) or spleen (14%).
This is in line with the concept that naı¨ve T cells have a
reduced capacity to migrate into non-lymphoid target organs
such as the kidney. In the kidneys of nephritic mice, the
relative abundance of effector T cells further increased from
day 5 (73%) to day 20 (88%), indicating the recruitment of
highly activated T cells into the inflamed kidney. Also in the
spleen, and to a lesser degree in the peripheral blood, of
nephritic mice the number of CD4þ T cells that displayed
the effector phenotype increased over time (Figure 1c).
Renal and systemic Th17 and Th1 immune responses show
differential time kinetics
To characterize the T cell response in more detail, renal
leukocytes were isolated at different time points after the
induction of nephritis and analyzed by multi-color flow
cytometry. IL-17- and IFN-g-producing CD4þ T cells (Th17
and Th1 cells, respectively) were identified by intracellular
cytokine staining after stimulation with phorbol 12-myristate
13-acetate/ionomycin. Representative flow cytometry ana-
lyses of CD4þ T cells from nephritic mice at day 5, day 20,
and from a non-nephritic control are shown in Figure 2a. Th1
cells increased from day 7 onwards until day 20. In contrast,
renal Th17 infiltration started earlier, peaked on days 7–10,
and then declined (Figure 2b). Renal IL-17-/IFN-g-double-
positive CD4þ T cells were very rare (o1%). To validate the
flow cytometric analyses, we performed real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) analysis
of total renal cortex at different time points (Figure 2c).
Consistent with the flow cytometry data, renal IFN-g mRNA
expression increased until day 20 after nephritis induction,
whereas renal IL-17 expression was upregulated from day 3
onwards with a peak at day 10 after the induction of
nephritis.
To analyze the systemic cellular immune response during
the time course of nephritis, we measured the secretion of
IFN-g and IL-17 by splenocytes restimulated with sheep IgG,
the nephritogenic antigen in NTN (Figure 2d). In line with
the Th1/Th17 time course in the inflamed kidney, the IFN-g
level increased from day 10 up to day 20 (Figure 2d, left
panel). In contrast, IL-17 secretion by splenocytes was
upregulated earlier, starting from day 3 onwards with a peak
on day 5 (Figure 2d, right panel).
CD4þ T cells are the main producers of IL-17 during the
autologous phase of experimental glomerulonephritis
To characterize the cellular sources of renal IL-17 and IFN-g,
we isolated renal CD4þ and CD8þ T cells, as well as
CD11bþ monocytes/macrophages from the inflamed kidney
at three different time points by flow cytometric cell sorting
(purity 490%) and performed quantitative real-time RT-
PCR analysis for IL-17 and IFN-g mRNA expression (Figure
3a). In line with our fluorescence-activated cell sorting
(FACS) analysis, CD4þ T cells show the highest expression of
IL-17 during the autologous phase of the nephritis with a
peak around day 10. IL-17 expression in CD4þ T cells was
strongly decreased at day 20 compared to day 10. In contrast,
the IFN-g expression in CD4þ T cells further increased and
was maximal at day 20. CD8þ T cells also expressed IFN-g,
peaking at day 10, but at day 20 IFN-g expression was much
lower than that in the CD4þ subset. IL-17 mRNA expression
by CD8þ T cells and monocytes/macrophages was hardly
detectable. Flow cytometric analysis of IL-17 and IFN-g
production in CD8þ T cells confirmed that CD8þ T cells
produce IFN-g during the course of the nephritis, whereas
IL-17-producing CD8þ T cells were absent (Figure 3b).
Time-dependent function of Th17 and Th1 immune
responses in experimental glomerulonephritis
Next, we examined the functional importance of time-
dependent infiltration of Th17 and Th1 cells into the kidney.
To analyze the impact of Th17 and Th1 immune responses on
the early stage of the disease, IL-17A-deficient (IL-17/) and
IFN-g/ mice were analyzed 6 days after induction of NTN.
At this early time point, IL-17-deficient mice, but not IFN-
g/ mice, were partly protected from immune-mediated
kidney injury, as demonstrated by reduced formation of
glomerular crescents and tubulointerstitial injury compared
to nephritic wild-type mice (Figure 4a, left panels). As shown
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in the Supplementary Figure S1 online, similar effects were
observed by the early application of anti-IL-17 and anti-IFNg
antibodies to nephritic mice. To elucidate the effects of
IL-17 and IFN-g selectively during the later stage of nephritis,
in vivo neutralization of the respective cytokines with specific
anti-IL-1725 or anti-IFN-g26 antibodies was performed from
day 10 to day 20. In line with the late increase of IFN-g in the
nephritis, neutralization of IFN-g resulted in less crescent
formation as well as tubulointerstitial injury at day 20
compared with control IgG–treated wild-type mice, whereas
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Figure 1 |Time course of experimental crescentic glomerulonephritis. (a, b) Representative periodic acid–Schiff (PAS) and CD3 staining
of control and nephritic kidney sections (original magnification  400) at days 5 and 20. Quantification of (a, right panel) glomerular
crescent formation and (b, right panels) tubulointerstitial and glomerular CD3þ T cell infiltration (n¼ 5–8 per time point). Symbols represent
mean values±s.e.m. (c) Representative activation status of blood, spleen, and renal CD4þ T cells during the course of the nephritis. Blots
show CD44 and CD62L expression for CD4þ CD45þ cells. Numbers give the % values for naive (CD44low CD62Lþ ), central memory
(CD44high CD62Lþ ), and effector or effector memory T cells (CD62L CD44high) (n¼ 3–6 samples per group). Con, control; d, days;
h.p.f., high-power field; NTN, nephrotoxic nephritis.
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anti-IL-17 antibody treatment failed to reduce kidney injury
at this time point (Figure 4a, right panels). The same results
were obtained in nephritic IL-17/ and IFN-g/ mice 20 days
after nephritis induction (data not shown).
In accordance with the role of IL-17 as a potent inducer of
neutrophil-attracting chemokines, we observed that the renal
recruitment of Ly6G/Cþ neutrophils at day 6 was signifi-
cantly decreased in nephritic mice lacking IL-17 (Figure 4b),
providing a possible explanation for the early amelioration of
nephritis in these mice. At day 20, however, the abundant
infiltrates of F4/80þ macrophages and dendritic cells were
significantly reduced by IFN-g neutralization, but unchanged
in anti-IL-17-treated mice (Figure 4c). Both the early lack of
IL-17 and the late IFN-g neutralization reduced renal T cell
infiltration (data not shown).
The blood urea nitrogen (BUN) level on day 6 of NTN
was significantly decreased in nephritic IL-17/ mice com-
pared with their nephritic wild-type counterparts (Po0.05)
(Con, 32.0±1.0mg/dl; NTN sIgG, 46.8±2.1mg/dl; NTN
aIL-17, 36.0±3.0mg/dl; NTN aIFN-g, 40.5±3.2mg/dl)
(Figure 4d, left panel). At day 20 of NTN, however, we
found no significant changes in BUN level in nephritic wild-
type mice without or with antibody treatment for IL-17 or
IFNg (Figure 4d, right panel). Taken together, these experi-
ments suggest that during the early course of the disease (day
6), IL-17-driven neutrophil recruitment promotes renal
tissue damage, whereas in the later phase an IFN-g-associated
Th1 cell response leading to activation and infiltration of
macrophages predominates.
a
Kidney: flow cytometry
Kidney: flow cytometry
Kidney: qRT-PCR
Spleen: ELISA
20
Control
IF
N
-γ
IF
N
-γ
+
 
CD
4+
 
T
ce
lls
(%
 of
 al
l C
D4
+
)
m
R
N
A 
ex
pr
es
sio
n
(x-
fo
ld
 o
f c
on
tro
l)
Pr
ot
ei
n 
(pg
/m
l)
Pr
ot
ei
n 
(pg
/m
l)
IFN-γ
IFN-γ
IFN-γ
IL-17
IL-17
IL-17
NTN 5 d
IL-17
NTN 20 d
b
c
d
102
102
103
103
104
104
105
102
103
104
105
102
103
104
105
105 102 103 104 105 102 103 104 105
15
10
5
0
0
0
500
1000
1500
2000
2500
0
200
400
600
1
2
3
m
R
N
A 
ex
pr
es
sio
n
(x-
fo
ld
 o
f c
on
tro
l)
0
50
100
150
6
IL
-1
7+
 
CD
4+
 
T
ce
lls
(%
 of
 al
l C
D4
+
)
4
2
0
Co
n 1 d 3 d 5 d 7 d 10
 d
20
 d
Time after induction
Co
n 1 d 3 d
 
5 d 7 d 10
 d
20
 d
Time after induction
Co
n 1 d
 
3 d 5 d 7 d 10
 d
20
 d
Time after induction
Co
n
1 d 3 d 5 d 7 d 10
 d
20
 d
Time after induction
Co
n 1 d 3 d 5 d 7 d 10
 d
20
 d
Time after induction
Co
n 1 d 3 d 5 d 7 d 10
 d
20
 d
Time after induction
Figure 2 |Renal and systemic T helper (Th)17 and Th1 immune
responses show differential time kinetics. (a) Kidney: flow
cytometry. Flow cytometric analyses of interferon-g (IFN-g) and
interleukin (IL)-17 production by renal CD4þ T cells after
restimulation with phorbol 12-myristate 13-acetate (PMA)/
ionomycin as depicted in representative dot plots. (b) Kidney: flow
cytometry. Quantification of IFN-g- and IL-17-producing renal
CD4þ T cells at indicated time points (n¼ 5–8 per time point).
(c) Kidney quantitative real-time reverse transcriptase-polymerase
chain reaction (qRT-PCR). The time-dependent renal mRNA
expression of IFN-g and IL-17 was assessed by RT-PCR (n¼ 5–8 per
time point). (d) Spleen: enzyme-linked immunosorbent assay
(ELISA). The systemic immune response was determined by
measuring IFN-g and IL-17 secretion by splenocytes after sheep
immunoglobulin G (IgG) restimulation (n¼ 3–7 per time point).
Symbols represent mean values±s.e.m. Con, control; d, day; NTN,
nephrotoxic nephritis.
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Figure 3 |CD4þ T cells are the main producers of interleukin
(IL)-17 during the autologous phase of experimental
glomerulonephritis. (a) Analysis of IL-17 and interferon (IFN)-g
mRNA expression by real-time reverse transcriptase-polymerase
chain reaction (RT-PCR) of fluorescence-activated cell–sorted
(FACS) CD4þ or CD8þ T cells, as well as CD11bþ cells, isolated
from kidneys of nephritic wild-type mice on days (d) 6, 10, and 20
after induction of nephritis and non-nephritic wild-type controls
(n¼ 5–6 per group). (b) Representative intracellular IL-17 and IFN-
g FACS analysis of isolated renal leukocytes from control or
nephritic mice (on day 6 or 20 after induction of nephritis), gated
for CD45þCD3þCD8þ T cells. NTN, nephrotoxic nephritis.
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Transfer experiments of IL-17- and IFN-c-deficient
splenocytes into RAG1/ mice
We were then interested to study whether the time-dependent
function of Th17 and Th1 cells might be regulated by a direct
or indirect relationship between leukocyte-derived IL-17 and
IFN-g in experimental glomerulonephritis. Wild-type, IL-17/,
or IFN-g/ splenocytes were transferred into RAG1/ mice,
which lack T and B cells, and induced NTN. RAG1/ mice
reconstituted with wild-type splenocytes developed significant
renal injury examined by quantification of glomerular crescent
formation and tubulointerstitial injury. Nephritic RAG1/
mice receiving IL-17- or IFN-g-deficient splenocytes showed
significantly reduced glomerular crescent formation and in-
terstitial injury, compared with recipients of wild-type
splenocytes 10 days after the induction of nephritis (Figure 5a).
To examine a potential interaction of IL-17 and IFN-g
regarding renal Th17 and Th1 immune responses, intracel-
lular cytokine staining of renal leukocytes and renal mRNA
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Figure 4 | Time-dependent function of T helper (Th)17 and Th1 immune responses in experimental glomerulonephritis. (a, left panel)
Quantification of glomerular crescent formation and the interstitial area in controls (Con), nephritic wild-type (WT), nephritic interleukin (IL)-
17/ and nephritic interferon (IFN)g/ mice 6 days after nephritis induction and (a, right panel) at day 20 in nephritic WT mice treated
with anti-IL-17, anti-IFN-g, or control (immunoglobulin G (IgG)) antibodies. (b) Representative immunohistochemical staining of renal Ly6G/
Cþ neutrophil infiltration (original magnification  400). Quantification of neutrophil recruitment in nephritic WT, nephritic IL-17/, and
nephritic IFN-g/ mice at day 6 of nephrotoxic nephritis (NTN) (n¼ 3–6 per group). (c) Representative staining and quantification of renal
F4/80-positive monocytes/macrophages (M/M) dendritic cells (DCs) (original magnification  400) 20 days after NTN induction (n¼ 4–5 per
group). (d) Blood urea nitrogen (BUN) levels of controls, nephritic WT, nephritic IL-17/, and nephritic IFNg/ mice on day 6 after
induction of nephritis and on day 20 in nephritic WT mice treated with anti-IL-17, anti-IFN-g, or control (IgG) antibodies. Bars represent
means, and error bars indicate s.e.m. (*Po0.05). h.p.f., high-power field.
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expression were assessed. The analysis of nephritic RAG1/
mice reconstituted with IL-17/ splenocytes revealed a
reduction in Th1 cells in the kidney compared with those
injected with wild-type splenocytes, suggesting that IL-17 is
required for the full development of the renal Th1 response
(Figure 5b). The absence of leukocyte-derived IFN-g, in
contrast, increased the Th17 cell abundance in nephritic
RAG1/ kidneys (Figure 5b), pointing to an inhibitory
effect of IFN-g on the renal Th17 response. In line with the
flow cytometric analyses, renal IFN-g mRNA expression was
significantly reduced in nephritic RAG1/ mice in the absence
of lymphocyte-derived IL-17, while IL-17 mRNA was signi-
ficantly increased in nephritic RAG1/ mice reconstituted
with IFN-g-deficient splenocytes (Figure 5c). To elucidate the
systemic immune response in these reconstituted nephritic
RAG1/ mice, we analyzed cytokine production by sheep
IgG–restimulated splenocytes. Consistent with the results
obtained in the inflamed kidney, IL-17 production by
splenocytes in the absence of IFN-g-competent T and B cells
was increased. However, in contrast to the finding in the
inflamed target organ, the enzyme-linked immunosorbent
assay (ELISA) analysis of splenocyte supernatants from
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Figure 5 | Transfer experiments of interleukin (IL)-17- or interferon (IFN)-c-deficient splenocytes into nephritic RAG1/ mice.
(a) Representative periodic acid–Schiff (PAS)-stained kidney sections (original magnification  400) of RAG1/ control and nephritic
RAG1/ mice reconstituted with wild-type (WT), IL-17/, or IFN-g/ splenocytes at day 10 and quantification of glomerular crescent
formation and the interstitial area in the different groups (n¼ 4–5 per group). (b) Histogram of renal IL-17- or IFN-g-producing CD4þ T cells
in the different groups of nephritic RAG1/ mice (percentage of IFN-g- or IL-17-positive CD4þ T cells are representative of three
independent experiments). (c) Renal mRNA expression of IFN-g and IL-17 was measured by quantitative real-time RT-PCR (qRT-PCR). Data
are expressed as x-fold relative to control (n¼ 4 per group). (d) IFN-g and IL-17 production by restimulated splenocytes was determined by
enzyme-linked immunosorbent assay (ELISA) (n¼ 4 per group). (e) Blood urea nitrogen (BUN) levels of the different animal groups. Bars
represent means, and error bars indicate s.e.m. (*Po0.05). Con, control; NTN, nephrotoxic nephritis.
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nephritic RAG1/ mice reconstituted with IL-17/ cells
showed a significant increase, rather than a decrease, in
IFN-g production (Figure 5d). The BUN level of nephritic
RAG1/mice that received IFNg/ or IL-17/ splenocytes
were slightly reduced compared with nephritic RAG1/ mice
reconstituted with wild-type splenocytes without reaching
statistical significance (Figure 5e).
Renal CCL20 and CXCL9 expression are differentially
regulated by IL-17 and IFN-c in vivo and in vitro
Renal Th1 and Th17 cell recruitment and subsequent tissue
damage is regulated by chemokines and their receptors. In
particular, the CXCL9/CXCR3 and CCL20/CCR6 axes might
be of importance for Th1 and Th17 cell trafficking, res-
pectively. Interestingly, recent studies have provided evidence
for the existence of a positive feedback loop in that IFN-g
produced by Th1 cells enhances local CXCL9 and CXCL10
expression and thereby further amplifies the recruitment of
CXCR3-bearing Th1 cells.27 On the other hand, IL-17 is a
strong inducer of CCL20 expression, which is a potent
chemoattractant for CCR6-positive Th17 cells.28,29
To analyze whether sequential IL-17 and IFN-g expression
in the kidney correlates with renal expression of CCL20 and
CXCL9, respectively, we determined the expression level of
these chemokines during the time course of NTN by RT-PCR
(Figure 6a). CCL20 expression preceded early Th17 cell
infiltration in the kidney. Increased CCL20 expression was
detected at day 3 after induction of nephritis, peaked at day 5,
and gradually decreases at days 10 and 20. In contrast, the
expression of CXCL9 increased from day 5 onwards until day
20. The profile of the IFN-g-inducible expression of CXCL9
was consistent with the renal Th1 immune response during
the later phase of nephritis.
To investigate a potential interaction of IL-17 and IFN-g
on renal CCL20 and CXCL9 production, we induced
glomerulonephritis in IL-17- or IFN-g-deficient mice. As
expected, renal CCL20 and CXCL9 expressions were lower in
nephritic IL-17- and IFN-g-deficient mice at day 6, respec-
tively (Figure 6b). Furthermore, the expression of CXCL9
was attenuated in nephritic IL-17-deficient mice compared
with the wild-type group. To examine the cytokine effect on
renal chemokine expression during the later stages of nephritis,
animals were treated with either anti-IL-17 or anti-IFNg
antibody from day 10 to day 20. The blockade of IFN-g, as
expected, reduced the expression of CXCL9, but, most inter-
estingly, also increased the expression of CCL20 in the kidney
(Figure 6c), suggesting an inhibitory effect of IFN-g on the
CCR6 ligand.
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Figure 6 |Renal CCL20 and CXCL9 expression are differentially
regulated by interleukin (IL)-17 and interferon (IFN)c in vivo
and in vitro. (a) Renal mRNA expression of CCL20 and CXCL9 was
analyzed by reverse transcriptase-polymerase chain reaction
(RT-PCR) during the course of the nephritis. (b) CCL20 and CXCL9
mRNA expression in the kidneys of nephritic wild-type (WT),
IL-17/, or IFN-g/ mice at day (d) 6 (c) or in kidneys from
nephritic mice treated with neutralizing anti-IFN-g or anti-IL-17
antibodies at day 20. Data are expressed as x-fold of control
mRNA expression (n¼ 4–6 per group). (d, upper panel) CCL20 and
CXCL9 mRNA expression in mouse mesangial cells stimulated
with IL-17 (10 ng/ml) and/or IFN-g (10 ng/ml) for 4 h was assessed
by RT-PCR. (d, lower panel) CCL20 and CXCL9 protein production
was measured by specific enzyme-linked immunosorbent assay
(ELISA) in the supernatants after 18 h of stimulation in the
presence or absence of IL-17 (10 ng/ml) and/or IFN-g (10 ng/ml)
(n¼ 4–6 per group). Bars represent means±s.e.m. (*Po0.05). Con,
control; IgG, immunoglobulin G; NTN, nephrotoxic nephritis.
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To further characterize the interactions between IL-17 and
IFN-g in the regulation of renal chemokine expression, we
performed in vitro studies on a murine mesangial cell line.
Supporting the in vivo results, IL-17-induced expression of
CCL20 was significantly reduced in the presence of IFN-g on
the mRNA and protein levels. In contrast, IFNg-induced
mRNA and protein expression of CXCL9 (and CXCL10, data
not shown) was synergistically enhanced by IL-17. These
in vitro results were confirmed in mouse tubular cells,
another type of resident cell in the kidney that represents a
potential target of IL-17 and IFN-g (data not shown).
CXCR3 and CCR6 regulate renal Th1/Th17 cell recruitment
To determine the functional relevance of CXCR3 and CCR6
for renal Th1 and Th17 cell trafficking, intracellular cytokine
staining combined with chemokine receptor detection by
flow cytometric analysis were performed. Th1 cells in the
kidney of nephritic mice at day 20 (identified by IFN-g
production) expressed CXCR3 (460%), whereas renal IL-
17-producing Th17 cells at day 6 after NTN induction
primarily expressed CCR6 on their surface (465%) (Figure
7a). On the other hand, significant CCR6 expression on Th1
cells was not detectable and CXCR3 expression on Th17 cells
was much less prominent (data not shown). Th17 cell
recruitment into the kidney during the early phase of
nephritis (day 6) was reduced in CCR6-deficient mice when
compared with wild-type controls (Figure 7b). Furthermore,
20 days after nephritis induction, the frequency of Th1 cells
was markedly reduced in CXCR3-deficient mice compared
with the wild-type group (Figure 7c). These data underscore
the important function of the CCL20/CCR6 ligand–receptor
pair for early Th17 infiltration and the CXCL9/CXCR3 axis
for late Th1 trafficking into the kidney.
DISCUSSION
The recruitment of T cells into the kidney is a typical feature
of human and experimental crescentic glomerulonephritis
and is closely correlated to renal function.30 It has generally
been assumed that the cell-mediated immune reaction
leading to renal tissue injury in proliferative and crescentic
forms of glomerulonephritis is predominantly mediated by
IFN-g-producing Th1 cells.11 Recently, however, this concept
has been challenged by the identification of a new IL-17-
producing CD4þ effector T cell subset (Th17 cells)31,32 that
might be responsible for at least some immune-mediated
effects previously attributed to the Th1 pathway.33 We and
others were able to demonstrate the presence of Th17 cells in
the inflamed kidney,15,16 and consequently provided evidence
that the IL-23/IL-17 axis significantly contributes to renal
tissue injury in experimental glomerulonephritis.16–20 How-
ever, the specific impact of Th1 and Th17 cells and the
potential relationship between these two effector T cell
subsets remains to be elucidated.
This study provides the first detailed characterization of
the time-dependent function of Th1 and Th17 cells, in the
kidney and in secondary lymphoid tissue, in a well-
established T cell–mediated murine model of experimental
crescentic glomerulonephritis (nephrotoxic nephritis). Most
importantly, our data show that the interaction between IFN-
g- and IL-17-induced chemokines, namely CXCL9 (acting via
CXCR3 on Th1 cells) and CCL20 (acting via CCR6 on Th17
cells), might orchestrate the time-dependent trafficking and
function of renal Th1 and Th17 cells.
During the early stage of nephritis (days 5–10), Th17 cells
accumulated in the kidney and declined afterwards, whereas
the renal Th1 immune response increased until day 20
(assessed by renal CD4þ T cell intracellular cytokine staining
and mRNA expression). In line with this, analysis of the
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Figure 7 |CXCR3 and CCR6 regulate renal T helper (Th)1 and
Th17 cell recruitment. (a) Representative fluorescence-activated
cell sorting (FACS) analysis of renal Th1 and Th17 cells for
CXCR3 and CCR6 expression at days (d) 7 and 20 of nephrotoxic
nephritis (NTN), respectively (gated for CD4þ T cells). Further
gating on interferon (IFN)-gþ and interleukin (IL)-17þ cells
shows differential expression of CXCR3 and CCR6. Numbers are
representative of three experiments. (b) Histogram of renal IL-17-
producing Th17 cells in kidneys from controls and nephritic wild-
type (WT) or nephritic CCR6-deficient mice at day 6 after nephritis
induction. (c) Renal IFN-g-producing Th1 cells were quantified in
control, nephritic, and nephritic CXCR3/ mice at day 20. The
numbers of CD4þ T cells producing IL-17 or IFN-g are
representative of three independent experiments.
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systemic T cell response revealed that IL-17 production by
antigen-restimulated splenocytes precedes that of IFN-g.
Importantly, the early course of nephritis was significantly
ameliorated in IL-17/ mice, but not in IFNg/ mice in
terms of renal tissue injury, neutrophil infiltration, and BUN
levels (data not shown). In contrast, IFN-g blockade from
day 10 to day 20, using a neutralizing anti-IFNg antibody,
reduced monocyte recruitment and consecutive tissue injury
at day 20, whereas the application of a neutralizing anti-IL-17
antibody in this period had no significant effect. Taken
together, our data indicate the functional importance of both
the early ‘neutrophil-associated’ Th17 immune response and
the subsequent Th1 immune response, which is paralleled by
a more prominent mononuclear cell infiltrate, during the
course of glomerulonephritis. This finding might explain why
previous studies have reported overlapping, as well as
differential roles of Th1 and Th17 cells in similar models of
autoimmune disease,34 in particular when different time
points were analyzed.
The spatio-temporal pattern of early Th17 and late Th1
immune response suggests the existence of an interaction of
these CD4þ T cell subsets in the differentiation and the
effector phase. Our data from cultured splenocytes (see
Figure 5d) are in line with recent studies that have indicated a
reciprocal regulation of Th1 and Th17 immune responses
during the T cell priming phase in secondary lymphoid
organs (reviewed in Damsker et al.35) There is some evidence
that mediators involved in Th1 development may down-
regulate lineage-specific transcription factors that are essen-
tial for differentiation of Th17 cells and vice versa,35,36
resulting in ‘cross-inhibition’ of Th1 and Th17 responses on
the systemic level.
To study a potential functional interaction of Th1 and
Th17 cells in our model of glomerulonephritis, we trans-
ferred spleen cells from IFN-g/, IL-17/, and wild-type
mice into RAG1/ animals, which lack T and B cells, and
subsequently induced nephritis. This experimental system of
reconstituting RAG1/ mice with lymphocyte populations
from knockout mice has proven to be very useful in
immunology and also recently in the field of nephrology19
because it allows rapid assembly of an immune system from
defined components to clarify which leukocyte-derived
factors (in our case IL-17 and IFN-g) are of importance in
the disease model.37 Analyses were performed 10 days after
nephritis induction, a time point when both T cell subsets
were present in the kidney and contributed to glomerular
crescent formation. The lack of IFN-g in nephritic RAG1
knockout animals led to a markedly increased systemic and
renal Th17 immune response. Interestingly, the transfer of
IL-17/ spleen cells into nephritic RAG1/mice resulted in
lower renal IFN-g mRNA expression and reduced IFN-g
production by renal CD4þ T cells. This was not a
consequence of a downregulated systemic IFN-g immune
response, as IFN-g production in the spleen was even
enhanced in the absence of IL-17. These data indicate a
more complex interaction of Th1–Th17 immune response
than assumed previously. In addition to the reciprocal rela-
tionship between Th17 and Th1 cell generation in secondary
lymphoid organs, such as the spleen, IL-17 and IFN-g might
actively regulate the target organ-specific ‘milieu’, resulting in
the differential time-dependent attraction of Th1 vs. Th17
cells. The first evidence for this hypothesis was provided by
Khader et al.,38 who showed in a model of Mycobacterium
tuberculosis lung infection that infiltrating IL-17-producing
CD4þ T cells in the lung trigger the production of
chemokines that recruit Th1 cells, which ultimately restrict
bacterial growth.
In general, chemokines and chemokine receptors play a
crucial role in the regulation of T cell trafficking and
activation. Both patient material analyses and experimental
studies using rodent models of experimental glomerulone-
phritis have highlighted the significance of these molecule
families in renal inflammation.39,40 We were therefore
interested in examining whether Th1 and Th17 characteristic
chemokines and their receptors might play a role in the
observed interplay of renal Th1 and Th17 immune response.
We focused on the role of CCL20/CCR6 and CXCL9/CXCR3,
as recent publications by us and others have indicated an
important role of these ligand–receptor pairs in renal CD4þ
T cell trafficking.16,41–43 The renal CCL20 expression pre-
ceded Th17 recruitment, whereas CXCL9 expression peaked
at the time point of the highest Th1 immune response.
Furthermore, using nephritic CCR6- and CXCR3-deficient
mice, we could clearly demonstrate the unique importance of
the CCL20/CCR6 and CXCL9/CXCR3 axes for renal Th17
and Th1 cell infiltration. However, we cannot rule out that
additional chemokines (and receptors) might be involved in
this process. Next, renal chemokine expression was assessed
in nephritic IL-17- and IFN-g-deficient mice (at the early
time point) or after neutralization of these cytokines (at the
late time point). Induction of nephritis in IL-17/ mice led
to reduced renal CCL20 and CXCL9 expression at day 6.
Most importantly, IFN-g neutralization from day 10 to day
20 (to selectively target the late T cell immune response) in
nephritic mice resulted in enhanced renal CCL20 expression
at day 20. This suggests an inhibitory effect of IFN-g on renal
CCL20 expression.
To analyze the interaction of IL-17 and IFN-g with respect
to renal CCL20 and CXCL9 expression in more detail, we
performed in vitro studies using mouse mesangial cells. IL-
17-induced CCL20 mRNA and protein formation was
significantly reduced in the presence of IFN-g, whereas
IFN-g-induced CXCL9 expression was markedly amplified by
IL-17. These results are in line with our in vivo findings and
suggest that the early recruitment of IL-17-producing Th17
cells triggers the expression of CXCL9 in the kidney and
thereby drives the infiltration of CXCR3-bearing Th1 cells.
Later, Th1 cell–derived IFN-g might in turn inhibit local
CCL20 expression. Such a feedback loop would limit the
trafficking of highly pathogenic Th17 cells into the kidney
and might act as a brake to control against an overwhelming
Th17 immune response.
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During the preparation of this manuscript, Odobasic
et al.44 reported that IL-17 predominantly promotes the early
stages of the disease in murine crescentic glomerulonephritis,
which is in line with our results. However, beside this point
there are major differences between these studies: (1) We did
not find an aggravated course of the disease during the later
phase of nephritis by application of a neutralizing anti-IL-17
antibody or in IL-17-deficient mice (data not shown), and in
particular could not detect a counter-regulated enhanced
renal Th1 immune response. In contrast, one of our major
finding is that the renal Th1 response is triggered by IL-17.
(2) Our analyses focused on the renal T cell immune
response. Therefore, we established the sophisticated method
of cytokine staining of CD4þ T cells isolated from the
kidney. We strongly believe that analysis in the target organ
itself in combination with the assessment of the systemic
response is pivotal for a better understanding of T
cell–mediated injury in crescentic glomerulonephritis. This
point was not addressed by the Holdsworth–Kitching group.
(3) Most importantly, this is the first description of a direct
intrarenal cross-regulation between Th1 and Th17 effector
cytokines and the CXCL9/CXCR3 and CCL20/CCR6 axes.
Recent findings have indicated that non-CD4þ T cells are
capable of producing IL-17, including gdT cells,45 lymphoid
tissue inducer cells,46 invariant natural killer T cells,47 and
potentially neutrophils.48 These IL-17þ , in part innate-like,
immune cells might reside in the target organ where they
incite a rapid immune response upon activation even before
the first CD4þ T cells see their cognate antigens and
differentiate into Th17 cells. A detailed analysis of non-
CD4þ IL-17-producing leukocytes during the early stage of
the nephritis would be of great interest, and awaits further
studies. However, in the T cell–dependent autologous phase
of the nephritis, which was studied here, CD4þ T cells are the
dominant IL-17-producing cell type in the inflamed kidney.
In summary, this study characterizes the time-dependent
function of the two major effector T cell subsets in
experimental crescentic glomerulonephritis. We could show
that during the early stage of the disease, the Th17-mediated
immune response predominates, whereas at later stages, Th1
cells are the critical mediators of renal tissue injury. Most
interestingly, our findings provide the first mechanistic
evidence for a cytokine–chemokine-driven feedback loop
that might orchestrate the observed differential Th1 and
Th17 cell infiltration into the inflamed kidney. Better
understanding of renal Th cell responses will help to establish
more specific and individualized therapeutic strategies.
MATERIALS AND METHODS
Animals
CCR6/, RAG1/, and IFN-g/ mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). IL-17/ mice were provided
by Y Iwakura (Center for Experimental Medicine, Institute of
Medical Science, University of Tokyo, Japan),49 and CXCR3-
deficient mice were generated by our group as described previously25
(all C57BL/6 background). Knockout mice underwent embryo tran-
sfer to meet the general standards of our institution. Age-matched
C57BL/6 wild-type controls (8–10 weeks old) were also derived from
the strain bred in our animal facility. All mice were raised in specific
pathogen-free conditions. Animal experiments were performed
according to national and institutional animal care and ethical
guidelines and were approved by local ethical committees.
Induction of nephrotoxic nephritis and functional studies
NTN was induced in 8–10 weeks old male C57BL/6 wild-type or
gene-deficient mice by intraperitoneal injection of 0.5ml of nephro-
toxic sheep serum as described previously.50 Blood samples for BUN
measurement were obtained at the time of being killed.
Real-time RT-PCR analysis
Total RNA of the renal cortex or FACS-sorted T cells and
monocytes/macrophages was prepared according to standard labo-
ratory methods. Real-time PCR was performed for 40 cycles with
1.5 ml of complementary DNA samples in the presence of 2.5ml
(0.9 mM) specific murine primers (primer sequences are available
upon request) and 12.5 ml of 2 Platinum SYBR Green qPCR
Supermix (Invitrogen, Karlsruhe, Germany) in a Step One Plus Real-
time PCR System (Applied Biosystems, Foster City, CA). All samples
were run in duplicate and normalized to 18S rRNA to account for small
variabilities in RNA and complementary DNA content.
Morphological examinations
Light microscopy and immunohistochemistry were performed by
routine procedures. Crescent formation was assessed in 30 glomeruli
per mouse in a blinded manner in PAS-stained paraffin sections.50
As a measure of tubulointerstitial injury, the interstitial area was
estimated by point counting four independent areas of renal cortex
per mouse in low magnification fields ( 200), as described
previously.42 Paraffin-embedded sections (2mm) were either stained
with an antibody directed against the pan-T cell marker CD3
(A0452; Dako, Hamburg, Germany), the monocyte/macrophage cell
marker F4/80 (BM8; BMA, Augst, Switzerland), or the neutrophil
marker Ly6 G/C (NIMP-R14; Hycult Biotech, Uden, the Nether-
lands), and developed with a polymer-based secondary antibody–
alkaline phosphatase kit (POLAP; Zytomed, Berlin, Germany).
CD3þ cells in 30 glomerular cross-sections, F4/80þ and CD3þ cells
in 30 tubulointerstitial high-power fields (magnification  400),
and neutrophils in 10 low-power fields (magnification  200) per
kidney were counted by light microscopy in a blinded manner.28
Leukocyte isolation from kidney and spleen
Previously described methods for leukocyte isolation from murine
kidneys were used.16 In brief, kidneys were finely minced and
digested for 45min at 37 1C with 0.4mg/ml collagenase D (Roche,
Mannheim, Germany) supplemented with 10% heat-inactivated
fetal calf serum (Invitrogen). Cell suspensions were sequentially
filtered through 70 and 40 mm nylon meshes and washed with
Hank’s balanced salt solution without Ca2þ and Mg2þ (Invitro-
gen). Single-cell suspensions were separated using Percoll density
gradient (70 and 40%) centrifugation. The leukocyte-enriched cell
suspension was aspirated from the Percoll interface. In the case of
spleen single-cell suspensions, erythrocytes were lysed with ammo-
nium chloride. Subsequently, cells were washed several times with
Hank’s balanced salt solution and resuspended in RPMI 1640 with
10% fetal calf serum (Invitrogen). Viability of the cells was assessed
by Trypan blue staining before in vitro culturing of 4 106 cells per ml
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for 60 h in the presence of sheep IgG (Sigma-Aldrich, Mu¨nchen,
Germany).
Flow cytometry
For FACS analysis, renal leukocyte suspensions were stained for
20min at 4 1C with the following fluorochrome-conjugated
antibodies CD45 (30-F11), CD3 (17A2), CD4 (GK1.5), CD8
(53-6.7), CD11b (M1/70), CD44 (IM7), and CD62L (MEL-14)
(BD Biosciences, Franklin Lakes, NJ or eBioscience, San Diego, CA).
Before antibody incubation, unspecific staining was blocked with
normal mouse serum (Sigma-Aldrich, Mu¨nchen, Germany). Stain-
ing of intracellular IFN-g and IL-17 was performed as described
recently.16 In brief, cells were activated by incubation at 37 1C, 5%
CO2 for 5 h with phorbol 12-myristate 13-acetate (50 ng/ml; Sigma)
and ionomycin (1 mg/ml; Calbiochem-Merck, Darmstadt, Germany)
in X-VIVO medium (Lonza AG, Walkersville, MD). After 30min of
incubation, Brefeldin A (10 mg/ml; Sigma) was added. After several
washing steps and staining of cell surface markers, cells were
incubated for 20min at 4 1C in Cytofix/Cytoperm (BD Biosciences)
to permeabilize cell membranes. Then, intracellular IFN-g and IL-17
were stained using a rat anti-mouse IFN-g antibody (XMG1.2; BD
Biosciences) and an anti-mouse IL-17 antibody (TC11-18H10; BD
Biosciences). Analyses were performed on a Becton & Dickinson
(BD) LSRII System using the Diva software (San Jose, CA). Renal
CD45þCD3þCD4þ or CD8þ T cells or CD11bþ monocytes/
macrophages were isolated and sorted using FACS Aria III (BD) cell
sorter (Diva software).
Cell transfer experiments
A total of 5 106 cells isolated from the spleens of naı¨ve wild-type,
IL-17/, or IFN-g/ mice were transferred into recipient RAG1/
by intravenous injection 24 h before the induction of nephritis.
Neutralization experiments
For these experiments, a neutralizing rat antibody to mouse IFN-g
(clone XMG1.2),26 or a mouse antibody to IL-17A (clone MM17F3),25
were used at 500 mg per mouse. The antibodies were injected
intraperitoneally on days 10 and 15 after induction of NTN. Rat or
mouse IgG at 500 mg per mouse was used as a control.
Cell culture experiments
Mouse mesangial cells51 were cultured in Dulbecco’s modified
Eagle’s medium (Life Technologies-BRL/Invitrogen, Karlsruhe,
Germany) containing 10% fetal calf serum, 100U/ml penicillin,
and 100mg/ml streptomycin (Life Technologies-BRL/Invitrogen) at
37 1C, 5% CO2. Before stimulation, confluent cells were incubated in
serum-free Dulbecco’s modified Eagle’s medium for 24 h. Mouse
mesangial cells were stimulated with IL-17 (10 ng/ml) or IFN-g
(10ng/ml) alone, or with a combination of both cytokines (PeproTech,
Hamburg, Germany). After 4 h of incubation, the expression CXCL9
and CCL20 mRNA was analyzed. CXCL9 and CCL20 protein levels
were determined after 24 h in the supernatants by specific ELISA,
according to the manufacturer’s instructions (R&D Systems,
Wiesbaden, Germany).
Statistical analysis
Differences between two individual experimental groups (of
normally distributed values) were compared by a two-tailed t-test.
In the case of multiple comparisons, one-way analysis of variance
with Bonferroni’s multiple comparisons test was used. Experiments
that did not yield enough independent data for statistical analysis
because of the experimental setup were repeated at least three times.
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